Results 271 to 280 of about 132,339 (311)
Some of the next articles are maybe not open access.

Prophylactic Neuroprotection

Current Drug Targets, 2007
Ischemic brain injury can be anticipated in a number of clinical settings such as procedures associated with a high-risk for stroke, patients with transient ischemic attacks or minor strokes who are at substantial risk for early recurrence and patients with multiple vascular risk factors with an enhanced risk for ischemic stroke over many years.
Savitz, Sean I., Fisher, Marc
openaire   +3 more sources

Estrogens and neuroprotection

Trends in Endocrinology & Metabolism, 2002
In recent years, we have become increasingly aware that estrogen is a gonadal hormone that exerts diverse non-reproductive actions on multiple organs and in multiple physiological systems. Amongst these, estrogen has profound effects on plasticity and cell survival of the adult brain.
openaire   +2 more sources

Neurogenic Neuroprotection

Cellular and Molecular Neurobiology, 2003
1. Stimulation of the rostral-ventromedial pole of the cerebellar fastigial nucleus exerts powerful effects on systemic and cerebral circulation. 2. Excitation of fibers passing through the fastigial nucleus evokes sympathoactivation and increases in arterial pressure. 3.
Eugene V, Golanov, Ping, Zhou
openaire   +2 more sources

Purines and Neuroprotection

2003
The activation of adenosine A1, A2 andA3 receptors can protect neurones against damage generated by mechanical or hypoxic/ischaemic insults as well as excitotoxins. A1 receptors are probably effective by suppressing transmitter release and producing neuronal hyperpolarisation.
openaire   +2 more sources

Perioperative neuroprotection

Best Practice & Research Clinical Anaesthesiology, 2010
The endpoint of all cerebral injuries like stroke, global cerebral ischemia during cardiac arrest, cardiac, vascular, or brain surgery or head trauma is the inadequate supply of the brain with oxygen and glucose, which triggers a characteristic pathophysiologic cascade leading to neuronal death. Many methods and agents have been investigated to produce
Klaus Ulrich, Klein, Kristin, Engelhard
openaire   +2 more sources

Neuroprotective Therapy

Seminars in Neurology, 1998
Neuroprotective therapy for stroke remains unproven despite its ability to substantially reduce injury in animal stroke models. Based on an understanding of the cascade of biochemical events that follow interruption of blood flow to the brain, various neuroprotective drugs have been tested in clinical studies, but none have been shown to improve ...
S L, Hickenbottom, J, Grotta
openaire   +3 more sources

Phytoestrogens as neuroprotectants

Drugs of Today, 2009
Recent large clinical trials demonstrating deleterious effects of postmenopausal hormone replacement therapy have raised interest in the use of food products and extracts containing phytoestrogens as potential safe alternatives for menopausal symptoms, age-related cognitive decline and neurodegenerative diseases.
openaire   +2 more sources

Endocannabinoids and Neuroprotection

Science's STKE, 2002
Traumatic brain injury (TBI) releases harmful mediators that lead to secondary damage. On the other hand, neuroprotective mediators are also released, and the balance between these classes of mediators determines the final outcome after injury. Recently, it was shown that the endogenous brain cannabinoids anandamide and 2-Arachidonoyl glycerol (2-AG ...
R, Mechoulam, M, Spatz, E, Shohami
openaire   +2 more sources

BILOBALIDE AND NEUROPROTECTION

Pharmacological Research, 2002
In vivo studies have indicated that systemically administered bilobalide, a sesquiterpene trilactone constituent of Ginkgo biloba leaf extracts, can reduce cerebral edema produced by triethyltin, decrease cortical infarct volume in certain stroke models, and reduce cerebral ischemia.
openaire   +2 more sources

Cannabinoids and Neuroprotection

Molecular Neurobiology, 2001
Cannabinoid compounds are endowed with pharmacological properties that make them interesting candidates for therapeutic development. These properties have been known since antiquity. However, in the last decade extremely important advances in the understanding of the physiology, pharmacology, and molecular biology of the cannabinoid system have given ...
Grundy, Robert   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy